CVS Health (NYSE: CVS) isn't having a good year. It is facing multiple headwinds and slow revenue growth, and investors are ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated ...

The Federal Trade Commission has brought an administrative complaint against three of the country's largest pharmacy benefit ...

The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of ...

This week's dividend activity included increased payouts from Microsoft (NASDAQ:MSFT) and JPMorgan (NYSE:JPM) as well as ...

We recently compiled a list of the 10 Best Fortune 500 Stocks To Buy Now. In this article, we are going to take a look at ...

CVS Health ( NYSE: CVS) subsidiary Oak Street Health has reached a $60M settlement with the Department of Justice to resolve ...

CVS Health Corp. closed $24.83 short of its 52-week high ($83.25), which the company reached on January 8th.

The owner of one of the three largest pharmacy middlemen in the United States on Tuesday filed suit to quash an attempt by ...

The US Federal Trade Commission said that CVS Health's Caremark, Cigna's Express Scripts, and UnitedHealth Group's Optum ...

The FTC sued UnitedHealth Group’s Optum unit, CVS Caremark and Cigna’s Express Scripts for allegedly steering diabetes ...